Literature DB >> 15132916

[Preparation and identification of monoclonal antibodies against CD100 molecule].

Xiao-guang Xu1, Yong Zhu, Xue-song Liu, Ying Tian, Yun-xin Cao, Yi Hu, Bo-quan Jin.   

Abstract

AIM: To prepare and identify the monoclonal antibodies (mAbs) against CD100.
METHODS: BALB/c mice were immunized with eukaryotic expressed CD100 protein. The splenocytes from immunized mice were fused with Sp2/0 cells and the positive hybridoma clones were screened by indirect ELISA and mAbs reacting to CD100 antigen were identified by indirect immunofluorescent staining and flow cytometry with human acute T lymphoblastic leukemia cell line MOLT-4, activated human PBMC, gibbon T lymphocyte cell line MLA-144 and monkey EBV-transformed B lymphoblast cell line(BLCL).
RESULTS: Seven hybridomas secreting mAbs against CD100 molecule were obtained. All the mAbs could react to natural CD100 expressed on human MOLT-4 and activated PBMCs as well as monkey BLCL cells, and six out of them could react to gibbon MLA-144 cells.
CONCLUSION: A set of mAbs recognizing CD100 molecule expressed on human, monkey and gibbon cells are obtained, which may provide an useful tool for studying the structure-function relationship of CD100 molecule of human, as well as gibbon and monkey.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15132916

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  4 in total

1.  CD8low CD100- T Cells Identify a Novel CD8 T Cell Subset Associated with Viral Control during Human Hantaan Virus Infection.

Authors:  Bei Liu; Ying Ma; Yusi Zhang; Chunmei Zhang; Jing Yi; Ran Zhuang; Haitao Yu; Angang Yang; Yun Zhang; Boquan Jin
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets.

Authors:  Peipei Mou; Zhao Zeng; Qiang Li; Xiaohui Liu; Xiaoran Xin; Kenneth M Wannemacher; Changgeng Ruan; Renhao Li; Lawrence F Brass; Li Zhu
Journal:  Blood       Date:  2013-04-05       Impact factor: 22.113

3.  Increased levels of plasma soluble Sema4D in patients with heart failure.

Authors:  Qiongyu Lu; Ningzheng Dong; Qi Wang; Wenxiu Yi; Yuxin Wang; Shengjie Zhang; Haibo Gu; Xin Zhao; Xiaorong Tang; Boquan Jin; Qingyu Wu; Lawrence F Brass; Li Zhu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Elevated plasma soluble Sema4D/CD100 levels are associated with disease severity in patients of hemorrhagic fever with renal syndrome.

Authors:  Bei Liu; Ying Ma; Jing Yi; Zhuwei Xu; Yu Si Zhang; Chunmei Zhang; Ran Zhuang; Haitao Yu; Jiuping Wang; Angang Yang; Yun Zhang; Boquan Jin
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.